Birdwatch Archive

Birdwatch Note

2024-06-07 09:59:57 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

レーザーを照射する歯周病治療器としては、Millennium Dental Technologies社からLANAPが2016年に米国FDAで承認され、既に販売されており、「世界初」ではありません。 https://www.accessdata.fda.gov/cdrh_docs/pdf15/k151763.pdf https://www.lanap.com/laser-dentistry/periolase-mvp-7/ 販売を開始した株式会社エーゼットのプレスリリースでは、"世界で初めて歯周病の医療機器として日本で承認された「ブルーラジカル P-01」"とされています https://prtimes.jp/main/html/rd/p/000000001.000143026.html

Written by E4497A3DFDD1CF9572DCF58DA4B8AE54E8C9DB751C3FE894FDD9F6ED5C3223DB
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1799001149145801157

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1799018450674971090
  • noteId - 1799018450674971090
  • participantId -
  • noteAuthorParticipantId - E4497A3DFDD1CF9572DCF58DA4B8AE54E8C9DB751C3FE894FDD9F6ED5C3223DB Participant Details
  • createdAtMillis - 1717754397443
  • tweetId - 1799001149145801157
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • レーザーを照射する歯周病治療器としては、Millennium Dental Technologies社からLANAPが2016年に米国FDAで承認され、既に販売されており、「世界初」ではありません。 https://www.accessdata.fda.gov/cdrh_docs/pdf15/k151763.pdf https://www.lanap.com/laser-dentistry/periolase-mvp-7/ 販売を開始した株式会社エーゼットのプレスリリースでは、"世界で初めて歯周病の医療機器として日本で承認された「ブルーラジカル P-01」"とされています https://prtimes.jp/main/html/rd/p/000000001.000143026.html

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-06-07 09:59:57 UTC
(1717754397443)
2024-06-07 21:23:20 UTC
(1717795400990)
CURRENTLY_RATED_HELPFUL 2024-06-11 02:27:24 UTC
(1718072844058)
CURRENTLY_RATED_HELPFUL 2024-06-07 21:23:20 UTC
(1717795400990)
CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2024-06-09 17:10:46 -0500 Rating Details
2024-06-08 23:18:33 -0500 Rating Details
2024-06-07 23:12:56 -0500 Rating Details
2024-06-07 17:36:14 -0500 Rating Details
2024-06-07 11:03:33 -0500 Rating Details
2024-06-07 09:58:55 -0500 Rating Details
2024-06-07 08:31:31 -0500 Rating Details
2024-06-07 08:10:25 -0500 Rating Details
2024-06-07 08:03:11 -0500 Rating Details
2024-06-07 07:56:15 -0500 Rating Details
2024-06-07 07:26:31 -0500 Rating Details
2024-06-07 06:13:18 -0500 Rating Details
2024-06-07 06:08:17 -0500 Rating Details
2024-06-07 05:55:38 -0500 Rating Details
2024-06-07 05:35:26 -0500 Rating Details
2024-06-07 05:32:18 -0500 Rating Details
2024-06-07 05:18:46 -0500 Rating Details
2024-06-07 05:14:31 -0500 Rating Details
2024-06-07 05:06:33 -0500 Rating Details
2024-06-07 14:48:06 -0500 Rating Details
2024-06-07 11:20:24 -0500 Rating Details
2024-06-07 09:47:21 -0500 Rating Details
2024-06-07 08:25:43 -0500 Rating Details
2024-06-07 08:21:26 -0500 Rating Details
2024-06-07 08:05:37 -0500 Rating Details
2024-06-07 08:03:10 -0500 Rating Details
2024-06-07 07:41:46 -0500 Rating Details
2024-06-07 07:39:59 -0500 Rating Details
2024-06-07 07:29:37 -0500 Rating Details
2024-06-07 07:15:15 -0500 Rating Details
2024-06-07 06:56:55 -0500 Rating Details
2024-06-07 06:49:06 -0500 Rating Details
2024-06-07 06:38:47 -0500 Rating Details
2024-06-07 06:35:50 -0500 Rating Details
2024-06-07 06:27:26 -0500 Rating Details
2024-06-07 06:08:10 -0500 Rating Details
2024-06-07 06:01:08 -0500 Rating Details
2024-06-07 05:56:38 -0500 Rating Details
2024-06-07 05:47:29 -0500 Rating Details
2024-06-07 05:38:52 -0500 Rating Details
2024-06-07 05:32:31 -0500 Rating Details
2024-06-07 05:31:57 -0500 Rating Details
2024-06-07 05:29:36 -0500 Rating Details
2024-06-07 05:26:42 -0500 Rating Details
2024-06-07 05:23:06 -0500 Rating Details
2024-06-07 05:20:58 -0500 Rating Details
2024-06-07 05:20:15 -0500 Rating Details
2024-06-07 05:19:42 -0500 Rating Details
2024-06-07 05:11:34 -0500 Rating Details
2024-06-07 05:10:40 -0500 Rating Details
2024-06-07 05:08:15 -0500 Rating Details
2024-06-07 05:06:34 -0500 Rating Details
2024-06-07 05:04:23 -0500 Rating Details
2024-06-10 12:47:05 -0500 Rating Details
2024-06-07 17:15:26 -0500 Rating Details
2024-06-07 16:21:35 -0500 Rating Details
2024-06-07 15:46:18 -0500 Rating Details
2024-06-07 10:56:54 -0500 Rating Details
2024-06-07 10:21:45 -0500 Rating Details
2024-06-07 08:55:14 -0500 Rating Details
2024-06-07 08:22:04 -0500 Rating Details
2024-06-07 07:54:50 -0500 Rating Details
2024-06-07 07:36:36 -0500 Rating Details
2024-06-07 07:17:40 -0500 Rating Details
2024-06-07 07:09:59 -0500 Rating Details
2024-06-07 06:25:11 -0500 Rating Details
2024-06-07 06:10:29 -0500 Rating Details
2024-06-07 05:53:22 -0500 Rating Details
2024-06-07 05:51:45 -0500 Rating Details
2024-06-07 05:49:43 -0500 Rating Details
2024-06-07 05:32:06 -0500 Rating Details
2024-06-07 05:19:55 -0500 Rating Details
2024-06-07 05:16:25 -0500 Rating Details
2024-06-07 05:12:35 -0500 Rating Details
2024-06-07 05:07:16 -0500 Rating Details
2024-06-07 05:05:50 -0500 Rating Details
2024-06-07 05:04:54 -0500 Rating Details
2024-06-21 18:09:02 -0500 Rating Details